Patent ID: 8603980
Filing Date: 2013-12-10
Classification: A61K,A61P,G01N

Abstract:
1. A method of delaying thrombus formation in a subject comprising: administering to the subject an effective amount of a compound that inhibits the activity of one or more glutamate receptors in non-neuronal cells, thereby delaying thrombus formation in a subject wherein the compound is selected from the group consisting of CNQX, NBQX, GYKI52466, GYKI53655, GYKI47261, cyclothiazide, YM90K, Zonampel (YM872), YM928, Perampanel (E2007), CP-465,022, ZK200775, Talampanel (LY300164), and Tezampanel (NGX424), LY382884, NS-102, UBP301, CX-516, CX-717, and philanthotoxin-343, and pharmaceutically acceptable salts, prodrugs, esters, and hydrates thereof.